Wannian Zhang

4.0k total citations
132 papers, 3.3k citations indexed

About

Wannian Zhang is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Wannian Zhang has authored 132 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 36 papers in Organic Chemistry and 29 papers in Infectious Diseases. Recurrent topics in Wannian Zhang's work include Cancer therapeutics and mechanisms (24 papers), Antifungal resistance and susceptibility (24 papers) and Synthesis and Biological Evaluation (16 papers). Wannian Zhang is often cited by papers focused on Cancer therapeutics and mechanisms (24 papers), Antifungal resistance and susceptibility (24 papers) and Synthesis and Biological Evaluation (16 papers). Wannian Zhang collaborates with scholars based in China, United States and Ireland. Wannian Zhang's co-authors include Chunquan Sheng, Zhenyuan Miao, Chunlin Zhuang, Guoqiang Dong, Jianzhong Yao, Shengzheng Wang, Zhuo Qu, Jian‐Qiang Yu, Wenya Wang and Yongqiang Zhang and has published in prestigious journals such as Hepatology, Chemical Communications and Journal of Agricultural and Food Chemistry.

In The Last Decade

Wannian Zhang

128 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wannian Zhang China 33 1.8k 1.2k 485 384 312 132 3.3k
Chunlin Zhuang China 33 2.4k 1.4× 1.7k 1.4× 519 1.1× 500 1.3× 422 1.4× 159 4.7k
Petr Džubák Czechia 28 2.1k 1.2× 960 0.8× 466 1.0× 258 0.7× 166 0.5× 157 3.5k
Zhenyuan Miao China 34 1.9k 1.1× 2.6k 2.2× 505 1.0× 474 1.2× 302 1.0× 109 4.4k
Xiao Ding China 28 1.2k 0.7× 745 0.6× 275 0.6× 408 1.1× 325 1.0× 118 2.7k
Hyung Ryong Moon South Korea 37 1.9k 1.0× 1.4k 1.1× 219 0.5× 399 1.0× 405 1.3× 235 4.8k
Chunyong Ding China 31 1.8k 1.0× 576 0.5× 406 0.8× 152 0.4× 170 0.5× 110 3.1k
Vincent Kam Wai Wong Macao 39 2.5k 1.4× 433 0.4× 495 1.0× 159 0.4× 781 2.5× 183 4.5k
Afzal Hussain Saudi Arabia 34 1.5k 0.8× 487 0.4× 324 0.7× 283 0.7× 99 0.3× 137 3.2k
Xianzhang Bu China 31 2.0k 1.1× 608 0.5× 601 1.2× 125 0.3× 147 0.5× 103 3.3k
Giuseppe La Regina Italy 33 945 0.5× 2.1k 1.7× 217 0.4× 469 1.2× 178 0.6× 105 3.4k

Countries citing papers authored by Wannian Zhang

Since Specialization
Citations

This map shows the geographic impact of Wannian Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wannian Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wannian Zhang more than expected).

Fields of papers citing papers by Wannian Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wannian Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wannian Zhang. The network helps show where Wannian Zhang may publish in the future.

Co-authorship network of co-authors of Wannian Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Wannian Zhang. A scholar is included among the top collaborators of Wannian Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wannian Zhang. Wannian Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Zhou, Ye, Zhenyang Li, Yunhui Li, et al.. (2022). Malignant progression of liver cancer progenitors requires lysine acetyltransferase 7–acetylated and cytoplasm‐translocated G protein GαS. Hepatology. 77(4). 1106–1121. 11 indexed citations
4.
Zhao, Wenli, Yue Liu, Lijuan Xu, et al.. (2022). Targeting Necroptosis as a Promising Therapy for Alzheimer’s Disease. ACS Chemical Neuroscience. 13(12). 1697–1713. 18 indexed citations
5.
Hao, Yanan, Zhuo Qu, Jiao Li, et al.. (2022). Investigation on the chemical space of the substituted triazole thio-benzoxazepinone RIPK1 inhibitors. European Journal of Medicinal Chemistry. 236. 114345–114345. 13 indexed citations
6.
Wang, Yingli, Bo Zhang, Yang Niu, et al.. (2021). Biological Activity, Hepatotoxicity, and Structure-Activity Relationship of Kavalactones and Flavokavins, the Two Main Bioactive Components in Kava (Piper methysticum). Evidence-based Complementary and Alternative Medicine. 2021. 1–14. 8 indexed citations
7.
Xia, Chun‐Nian, et al.. (2021). Structure-based bioisosterism design of thio-benzoxazepinones as novel necroptosis inhibitors. European Journal of Medicinal Chemistry. 220. 113484–113484. 25 indexed citations
8.
Meng, Ning, Hua Tang, Hao Zhang, et al.. (2018). Fragment-growing guided design of Keap1-Nrf2 protein-protein interaction inhibitors for targeting myocarditis. Free Radical Biology and Medicine. 117. 228–237. 33 indexed citations
9.
Dong, Guoqiang, Ying Wu, Ying Sun, et al.. (2018). Identification of potent catalytic inhibitors of human DNA topoisomerase II by structure-based virtual screening. MedChemComm. 9(7). 1142–1146. 10 indexed citations
10.
Zhang, Xingjie, Zhi Qiang Meng, Zhiqiang Ma, et al.. (2018). Design and synthesis of novel water-soluble amino acid derivatives of chlorin p6 ethers as photosensitizer. Chinese Chemical Letters. 30(1). 247–249. 15 indexed citations
11.
Huang, Yahui, Guoqiang Dong, Huanqiu Li, et al.. (2018). Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections. Journal of Medicinal Chemistry. 61(14). 6056–6074. 91 indexed citations
12.
Huang, Yahui, Yu Li, Guoqiang Dong, et al.. (2018). Identification of pyrazolopyridine derivatives as novel spleen tyrosine kinase inhibitors. Archiv der Pharmazie. 351(8). 10 indexed citations
13.
Chen, Wei, Guoqiang Dong, Ying Wu, et al.. (2017). Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery. ACS Medicinal Chemistry Letters. 9(1). 34–38. 47 indexed citations
14.
Jiang, Yan, Chunlin Zhuang, Long Chen, et al.. (2017). Structural Biology-Inspired Discovery of Novel KRAS–PDEδ Inhibitors. Journal of Medicinal Chemistry. 60(22). 9400–9406. 25 indexed citations
15.
Liu, Na, Hua Zhong, Jie Tu, et al.. (2017). Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors. European Journal of Medicinal Chemistry. 143. 1510–1523. 19 indexed citations
16.
17.
Liu, Na, Shiping Zhu, Xianghua Zhang, et al.. (2016). The discovery and characterization of a novel scaffold as a potent hepatitis C virus inhibitor. Chemical Communications. 52(16). 3340–3343. 8 indexed citations
18.
Wu, Shanchao, et al.. (2014). Advance in anti-cancer lead-compounds derived from natural products. 32(5). 1 indexed citations
19.
Li, Yuxiang, Jianqiang Yu, Dai Xiu-ying, et al.. (2012). Analgesia effect of a fixed nitrous oxide/oxygen mixture on burn dressing pain: study protocol for a randomized controlled trial. Trials. 13(1). 67–67. 13 indexed citations
20.
Che, Xiaoying, Chunquan Sheng, Wenya Wang, et al.. (2009). New azoles with potent antifungal activity: Design, synthesis and molecular docking. European Journal of Medicinal Chemistry. 44(10). 4218–4226. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026